Summary by Futu AI
Petropharmacy Group Limited (the “Petropharmacy Group”) purchased 5,540,000 shares on the market on 24 April 2024 pursuant to its Restrictive Share Award Scheme adopted on 20 August 2018, representing approximately 0.046% of the total issued shares. The average purchase price of this batch of shares is approximately HK$6.184 per share for a total price of HK$34,261,200. The shares purchased will be held in trust by the Trustee and will benefit selected participants under the Plan. The Board of Directors will continue to review and decide whether to continue purchasing shares from the market in the future and the number of shares to be awarded to selected participants. The Chairman of Petrochemical Group, Tung Chen, issued the announcement on the same day.